VillageMD has turned out to be a challenging venture for Walgreens, which invested $5.2 billion in 2021 to take a majority ...

The U.S. healthcare segment reported Q2 revenue of $2.2 billion, a decrease of $23 million, reflecting lower fee-for-service ...

Walgreens Boots Alliance Inc. shares ended Tuesday’s session down 1.1% after the drugstore chain reported ...

Walgreens Boots Alliance entered into a $10 billion definitive agreement with private equity firm Sycamore Partners to take ...

Walgreens’ second-quarter report is one of its last financial disclosures before the struggling drugstore chain ends its ...

The drugstore chain booked pharmacy sales gains, and its struggling VillageMD clinic business delivered a smaller balance ...

Walgreens Boots Alliance reported quarterly profit that exceeded Wall Street’s expectations, marking a strong performance in ...

Walgreens delivered a better-than-expected fiscal second quarter and smaller loss a month after announcing that it would be ...

Drug store chain reports revenue and adjusted earnings that topped estimates as it prepares to be taken private ...

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the second quarter of fiscal 2025, which ended February 28, 2025.

The drugstore chain booked pharmacy sales gains, and its struggling VillageMD clinic business delivered a smaller balance sheet hit in the recently concluded quarter. Overall, Walgreens said ...